Shandong Weigao Group Medical Polymer Company Limited
Symbol: SHWGF
PNK
0.9575
USDDzisiejsza cena rynkowa
15.4080
Wskaźnik P/E
0.0000
Wskaźnik PEG
4.33B
Kapitalizacja MRK
- 0.02%
Rentowność DIV
Shandong Weigao Group Medical Polymer Company Limited (SHWGF) Sprawozdania finansowe
Bilans
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 1140.1 | 1157.2 | 1238.3 | |||||
balance-sheet.row.short-term-investments | 0 | 48.6 | 71.2 | 68.3 | |||||
balance-sheet.row.net-receivables | 0 | 1039.3 | 1016.6 | 963.4 | |||||
balance-sheet.row.inventory | 0 | 351.7 | 332.8 | 279.5 | |||||
balance-sheet.row.other-current-assets | 0 | 95.6 | 93.4 | 69.3 | |||||
balance-sheet.row.total-current-assets | 0 | 2626.7 | 2600 | 2550.5 | |||||
balance-sheet.row.property-plant-equipment-net | 0 | 1034 | 1051 | 1055.1 | |||||
balance-sheet.row.goodwill | 0 | 525.5 | 523 | 525.2 | |||||
balance-sheet.row.intangible-assets | 0 | 1507.3 | 770.5 | 807.4 | |||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 5235.1 | 1293.4 | 1332.6 | |||||
balance-sheet.row.long-term-investments | 0 | 309.5 | 316.4 | 346.4 | |||||
balance-sheet.row.tax-assets | 0 | 29.2 | 22.9 | 24.6 | |||||
balance-sheet.row.other-non-current-assets | 0 | -4488.3 | -512.8 | -512.8 | |||||
balance-sheet.row.total-non-current-assets | 0 | 2119.5 | 2171 | 2245.9 | |||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.total-assets | 0 | 4746.2 | 4771 | 4796.4 | |||||
balance-sheet.row.account-payables | 0 | 163.2 | 207.3 | 203.2 | |||||
balance-sheet.row.short-term-debt | 0 | 449 | 182.4 | 150 | |||||
balance-sheet.row.tax-payables | 0 | 33.8 | 25.7 | 23.6 | |||||
balance-sheet.row.long-term-debt-total | 0 | 210.8 | 488.3 | 542 | |||||
Deferred Revenue Non Current | 0 | 1.4 | 1.1 | 0.5 | |||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||
balance-sheet.row.other-current-liab | 0 | 396.8 | 410 | 409.2 | |||||
balance-sheet.row.total-non-current-liabilities | 0 | 286.9 | 538.3 | 668.5 | |||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.capital-lease-obligations | 0 | 14.2 | 15 | 9.1 | |||||
balance-sheet.row.total-liab | 0 | 1355.7 | 1391.3 | 1480.7 | |||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.common-stock | 0 | 64.4 | 65.7 | 71.7 | |||||
balance-sheet.row.retained-earnings | 0 | 2625.8 | 2475.7 | 2381.5 | |||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 87.6 | 178.7 | 160.6 | |||||
balance-sheet.row.other-total-stockholders-equity | 0 | 386.7 | 394.2 | 430.3 | |||||
balance-sheet.row.total-stockholders-equity | 0 | 3164.5 | 3114.3 | 3044.1 | |||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 4746.2 | 4771 | 4796.4 | |||||
balance-sheet.row.minority-interest | 0 | 217.6 | 255.5 | 257.3 | |||||
balance-sheet.row.total-equity | 0 | 3382.1 | 3369.8 | 3301.4 | |||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||
Total Investments | 0 | 358.1 | 387.6 | 414.7 | |||||
balance-sheet.row.total-debt | 0 | 674 | 685.6 | 701.1 | |||||
balance-sheet.row.net-debt | 0 | -417.6 | -400.4 | -468.9 |
Rachunek przepływów pieniężnych
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 405.4 | 351.7 | 302.4 | ||||
cash-flows.row.depreciation-and-amortization | 0 | 118.9 | 113 | 102.2 | ||||
cash-flows.row.deferred-income-tax | 0 | -469.7 | -381.9 | -294.9 | ||||
cash-flows.row.stock-based-compensation | 0 | 91.8 | 76.5 | 30.7 | ||||
cash-flows.row.change-in-working-capital | 0 | -158.8 | -38.1 | -30.3 | ||||
cash-flows.row.account-receivables | 0 | -124.1 | -40.2 | -106.1 | ||||
cash-flows.row.inventory | 0 | -80.2 | -27.9 | -37.9 | ||||
cash-flows.row.account-payables | 0 | 64.1 | -11.2 | 84.1 | ||||
cash-flows.row.other-working-capital | 0 | -18.6 | 41.3 | 29.6 | ||||
cash-flows.row.other-non-cash-items | 0 | 341 | 337.5 | 281.5 | ||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -166.2 | -180.2 | -146 | ||||
cash-flows.row.acquisitions-net | 0 | 4.9 | 219.6 | -19.6 | ||||
cash-flows.row.purchases-of-investments | 0 | -247.2 | -5.9 | -27.6 | ||||
cash-flows.row.sales-maturities-of-investments | 0 | 0.1 | 0.6 | 0.1 | ||||
cash-flows.row.other-investing-activites | 0 | 0 | 0.5 | 216.9 | ||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -408.3 | 34.6 | 23.8 | ||||
cash-flows.row.debt-repayment | 0 | -13.9 | -30.5 | -151.3 | ||||
cash-flows.row.common-stock-issued | 0 | -35.2 | 40.4 | 37.5 | ||||
cash-flows.row.common-stock-repurchased | 0 | -5.2 | -11.3 | -1.9 | ||||
cash-flows.row.dividends-paid | 0 | -110.4 | -101 | -101.6 | ||||
cash-flows.row.other-financing-activites | 0 | 40.3 | -176.3 | 10.5 | ||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -124.5 | -278.7 | -206.9 | ||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 96.2 | -54.4 | -57 | ||||
cash-flows.row.net-change-in-cash | 0 | -84 | 251.7 | 263.1 | ||||
cash-flows.row.cash-at-end-of-period | 0 | 1086 | 1170 | 918.3 | ||||
cash-flows.row.cash-at-beginning-of-period | 0 | 1170 | 918.3 | 655.2 | ||||
cash-flows.row.operating-cash-flow | 0 | 328.6 | 458.7 | 391.6 | ||||
cash-flows.row.capital-expenditure | 0 | -166.2 | -180.2 | -146 | ||||
cash-flows.row.free-cash-flow | 0 | 162.4 | 278.5 | 245.6 |
Wiersz rachunku zysków i strat
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 1871.6 | 2027.3 | 2041.4 | |||||
income-statement-row.row.cost-of-revenue | 0 | 970.9 | 1005.8 | 942.3 | |||||
income-statement-row.row.gross-profit | 0 | 900.7 | 1021.6 | 1099.1 | |||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||
income-statement-row.row.research-development | 0 | - | - | - | |||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||
income-statement-row.row.other-expenses | 0 | 6.6 | 10.3 | 10.9 | |||||
income-statement-row.row.operating-expenses | 0 | 581.1 | 566.3 | 622.9 | |||||
income-statement-row.row.cost-and-expenses | 0 | 1552 | 1572 | 1565.2 | |||||
income-statement-row.row.interest-income | 0 | 235.7 | 26.8 | 22.4 | |||||
income-statement-row.row.interest-expense | 0 | 273 | 28.5 | 21.7 | |||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||
income-statement-row.row.total-other-income-expensenet | 0 | 4.7 | 27.4 | -42.1 | |||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||
income-statement-row.row.other-operating-expenses | 0 | 6.6 | 10.3 | 10.9 | |||||
income-statement-row.row.total-operating-expenses | 0 | 4.7 | 27.4 | -42.1 | |||||
income-statement-row.row.interest-expense | 0 | 273 | 28.5 | 21.7 | |||||
income-statement-row.row.depreciation-and-amortization | 0 | 128.2 | 118.9 | 113 | |||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||
income-statement-row.row.operating-income | 0 | 319.6 | 455.3 | 476.1 | |||||
income-statement-row.row.income-before-tax | 0 | 324.3 | 482.7 | 434 | |||||
income-statement-row.row.income-tax-expense | 0 | 43.5 | 63.2 | 64.9 | |||||
income-statement-row.row.net-income | 0 | 283.2 | 405.4 | 351.7 |
Często zadawane pytania
Ile wynosi Shandong Weigao Group Medical Polymer Company Limited (SHWGF) aktywów ogółem?
Shandong Weigao Group Medical Polymer Company Limited (SHWGF) całkowite aktywa to 4746213417.000.
Jaki jest roczny przychód przedsiębiorstwa?
Roczny przychód to N/A.
Jaka jest marża zysku firmy?
Marża zysku firmy to 0.482.
Czym są wolne przepływy pieniężne firmy?
Wolne przepływy pieniężne to 0.075.
Jaka jest marża zysku netto przedsiębiorstwa?
Marża zysku netto to 0.152.
Jaki jest całkowity przychód firmy?
Całkowity przychód to 0.168.
Co to jest Shandong Weigao Group Medical Polymer Company Limited (SHWGF) zysk netto (dochód netto)?
Zysk netto (dochód netto) wynosi 283215434.000.
Jakie jest całkowite zadłużenie firmy?
Całkowite zadłużenie to 674011810.000.
Ile wynoszą koszty operacyjne?
Wydatki operacyjne to 581122121.000.
Jaka jest wartość gotówki firmy?
Środki pieniężne przedsiębiorstwa to 0.000.